Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs ABBOTT INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES ABBOTT INDIA ZYDUS LIFESCIENCES/
ABBOTT INDIA
 
P/E (TTM) x 20.7 49.0 42.3% View Chart
P/BV x 2.5 15.6 15.8% View Chart
Dividend Yield % 0.6 1.4 44.7%  

Financials

 ZYDUS LIFESCIENCES   ABBOTT INDIA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-22
ABBOTT INDIA
Mar-22
ZYDUS LIFESCIENCES/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs67423,902 2.8%   
Low Rs33114,553 2.3%   
Sales per share (Unadj.) Rs149.12,315.0 6.4%  
Earnings per share (Unadj.) Rs22.7375.9 6.0%  
Cash flow per share (Unadj.) Rs29.7407.0 7.3%  
Dividends per share (Unadj.) Rs2.50275.00 0.9%  
Avg Dividend yield %0.51.4 34.8%  
Book value per share (Unadj.) Rs166.11,306.2 12.7%  
Shares outstanding (eoy) m1,023.7421.25 4,817.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.48.3 40.6%   
Avg P/E ratio x22.151.2 43.2%  
P/CF ratio (eoy) x16.947.2 35.8%  
Price / Book Value ratio x3.014.7 20.6%  
Dividend payout %11.073.2 15.0%   
Avg Mkt Cap Rs m514,277408,573 125.9%   
No. of employees `000NANA-   
Total wages/salary Rs m21,7775,795 375.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m152,65249,193 310.3%  
Other income Rs m2,354774 304.1%   
Total revenues Rs m155,00649,967 310.2%   
Gross profit Rs m34,42710,875 316.6%  
Depreciation Rs m7,130661 1,078.7%   
Interest Rs m1,270191 664.9%   
Profit before tax Rs m28,38110,797 262.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,1172,810 182.1%   
Profit after tax Rs m23,2647,987 291.3%  
Gross profit margin %22.622.1 102.0%  
Effective tax rate %18.026.0 69.3%   
Net profit margin %15.216.2 93.9%  
BALANCE SHEET DATA
Current assets Rs m122,61438,530 318.2%   
Current liabilities Rs m78,39412,032 651.6%   
Net working cap to sales %29.053.9 53.8%  
Current ratio x1.63.2 48.8%  
Inventory Days Days936 1,515.1%  
Debtors Days Days802 3,735.5%  
Net fixed assets Rs m144,3823,541 4,077.2%   
Share capital Rs m1,024213 481.9%   
"Free" reserves Rs m168,97227,544 613.5%   
Net worth Rs m169,99627,756 612.5%   
Long term debt Rs m3,6210-   
Total assets Rs m266,99642,072 634.6%  
Interest coverage x23.357.5 40.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.61.2 48.9%   
Return on assets %9.219.4 47.3%  
Return on equity %13.728.8 47.6%  
Return on capital %17.139.6 43.1%  
Exports to sales %00.7 0.0%   
Imports to sales %14.310.2 140.0%   
Exports (fob) Rs mNA350 0.0%   
Imports (cif) Rs m21,8695,034 434.5%   
Fx inflow Rs m63,065415 15,214.7%   
Fx outflow Rs m21,8695,117 427.4%   
Net fx Rs m41,196-4,702 -876.1%   
CASH FLOW
From Operations Rs m21,0419,477 222.0%  
From Investments Rs m11,544-3,958 -291.6%  
From Financial Activity Rs m-8,683-6,374 136.2%  
Net Cashflow Rs m23,729-856 -2,773.4%  

Share Holding

Indian Promoters % 75.0 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 15.5 8.1 192.9%  
FIIs % 2.6 0.2 1,300.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 25.0 100.0%  
Shareholders   408,231 83,526 488.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on Cadila Healthcare vs Abbott India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Abbott India Share Price Performance

Period Cadila Healthcare Abbott India S&P BSE HEALTHCARE
1-Day 0.46% -1.07% -0.39%
1-Month -5.36% 3.67% -2.27%
1-Year -10.25% 6.78% -5.89%
3-Year CAGR 16.98% 17.21% 20.85%
5-Year CAGR -0.52% 29.71% 11.41%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Abbott India share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Abbott India the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Abbott India.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 11.0%.

Abbott India paid Rs 275.0, and its dividend payout ratio stood at 73.2%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Abbott India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 320 Points| PolicyBazaar Stake Sale| Oil & Gas and Auto Stocks Witness Most Selling(10:30 am)

Indian share markets opened on a negative note today halting their eight-day rally, amid a weak trend in global markets.